- The article discusses the launch of the 2023 Humana-Mays Healthcare Analytics Case Competition, which aims to showcase students' analytical abilities to solve real-world business problems. The competition offers a prize package of $90,000 for the winning teams. The stock of Humana Inc. (HUM) went up by 1.49% last night. The reason for the stock's increase is not mentioned in the article.
- CVS Health has made changes to its executive leadership team, giving added responsibilities to key members, in an effort to improve the company's healthcare strategy amidst recent scrutiny from Wall Street. The move comes at a challenging time for retail pharmacies, whose stock prices have been impacted negatively. CVS President and CEO, Karen S. Lynch, stated that the company is focusing on patient-centric innovation and improving overall health. The changes include Shawn Guertin becoming President of Health Services, Prem Shah becoming President of Pharmacy and Consumer Wellness, Michelle Peluso expanding her focus on creating a superior patient experience, and Brian Kane joining as President of Aetna. Humana's stock goes up due to the positive changes in CVS Health's leadership team and potential improvements in healthcare strategy.
- Humana (HUM) stock went up by 1.49% last night, and the article discusses the additional responsibilities given to members of the executive leadership team at CVS Health, which may have contributed to the stock increase.
- The article discusses the ongoing dispute between Elevance, a for-profit health insurer, and Bon Secours Mercy Health (BSMH) in Ohio, as well as the larger issue of insurers prioritizing profits over patient care. It highlights Elevance's history of denying claims and squeezing hospitals to accept lower rates. The article argues that these actions ultimately harm patients and healthcare providers while benefiting shareholders and top executives. The author, Wendell Potter, is a former executive of Cigna and Humana and a whistleblower in the industry.
- Humana (HUM) stock went up 0.18% last night, and the increase may be attributed to the approval of a dividend payment of USD 0.885 per share, which will be paid on November 3, 2023, to entitled BDR shareholders on September 27, 2023.
- Humana Inc. (HUM) stock rose 0.03% last night, but over the past five years, the stock has only risen 51%, which is below the market average, despite achieving compound earnings per share growth of 23% per year. The total shareholder return (TSR) for Humana over the last 5 years was 57%, exceeding the share price return, largely due to dividend payments. The TSR for the last twelve months was 2.2%, falling short of the market average. Overall, Humana's long-term performance has been positive, but investors should consider other factors before buying the stock.
- The article discusses how Humana stock has seen a 15% rise in a month, outperforming the broader S&P500 index and the reasons behind this growth. Despite the recent rise, the stock still has potential for further growth.
- Humana Inc. (HUM) stock went up 0.03% last night, potentially due to analysts raising its price target based on positive performance in the Medicare Advantage program, which provides comprehensive coverage beyond original Medicare.
- Humana (HUM) stock was down 2.78% last night, and the reason for the decline is not mentioned in the article. The article focuses on Humana's return on equity (ROE), which is currently at 19%, higher than the industry average of 11%. The company has shown decent growth, and its earnings growth potential seems positive. The article suggests that Humana is reinvesting its profits at a high rate of return, leading to substantial earnings growth. The future ROE is expected to be similar to the current ROE. Overall, the article presents a positive outlook on Humana's performance.
- The article discusses the impact of artificial intelligence (AI) on productivity and advises investors on how to approach AI stocks. Humana (HUM) stock went down because investors may be shifting away from "obvious" AI trades like hardware and services due to concerns such as higher inflation and interest rates, a large number of unprofitable AI firms, and the potential overvaluation of the sector. The article suggests that investors should consider stocks that are incorporating AI into their business models, such as Humana, along with firms like Deere and Interactive Brokers. Additionally, it highlights obstacles that could hinder the improvement of AI technology, such as energy usage and data quality issues.